Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study

<p>Introduction: Adjuvant immune checkpoint inhibitors (ICIs) may improve recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC). This study evaluated the effects of adjuvant ICI treatment duration on RFS and overall survival (OS) among patients with HCC at high ri...

詳細記述

書誌詳細

主要な著者:	Jia-Yong Su, Shao-Ping Liu, Xiao-Ling Xu, Jun-Jie Ou, Po-Hua Ye, Bin-Tong Zhao, Jia-Song Chen, Qiu-Mei Luo, Jin-Rong Liu, Fei-Min Tang, Jian-Rong Li, Da-Long Yang, Zhu-Jian Deng, Li-Xin Pan, Yao-Jie Li, Le Li, Zhen-Ming Qin, Xiu-Mei Liang, Yi-Li Ma, Liang Ma, Jian-Hong Zhong
フォーマット:	Artigo
言語:	Inglês
出版事項:	Karger Publishers 2025-01-01
シリーズ:	Liver Cancer
オンライン･アクセス:	https://karger.com/article/doi/10.1159/000542954
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!